臨床試驗

Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

NCT：NCT06364215 · TERMINATED

NCT IDNCT06364215

狀態TERMINATED

開始日期2024-10-08

完成時間2025-11-16

SponsorJorge Romero (OTHER)

First posted2024-04-15

Last updated2026-05-15

簡要摘要

The purpose of this study is to compare the efficacy and safety between pulmonary vein isolation (PVI) alone versus PVI with left atrial (LA) posterior wall isolation (PWI) using pulsed-field ablation (PFA) in the treatment of patients with paroxysmal atrial fibrillation (PAF).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。